Julia Zhe Xu
6PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 11, 2026
Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease.Anna Conrey, Nancy Asomaning, Ingrid Frey
|Oct 13, 2025
Tebapivat Improves Red Cell Deformability and Decreases Sickling in Patients With Sickle Cell Disease: A Phase 1 Trial Substudy.Julia Z Xu, Brian J Philips, Nelly K Kiriza
|May 19, 2022
Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches.Julia Zhe Xu, Swee Lay Thein
|May 16, 2022
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease.Julia Z Xu, Anna Conrey, Ingrid Frey
|Aug 26, 2018
Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease.Julia Z Xu, Melanie E Garrett, Karen L Soldano
Pageof 1
Frequent Collaborators
3 joint publications
Swee Lay Thein
2 joint publications
William A Eaton
1 joint publications
Melanie E Garrett
1 joint publications
Clary B Clish
1 joint publications
Allison E Ashley-Koch
1 joint publications
Marilyn J Telen
1 joint publications
Laxminath Tumburu
1 joint publications
Lenny Dang
1 joint publications
Penelope A Kosinski
1 joint publications
Brian J Philips